Review practical patient counseling and symptom management strategies that can help support long-term disease control goals among patients with polycythemia vera.
The FDA has approved a prefilled pen for ropeginterferon alfa-2b-njft in adult patients with polycythemia vera, providing a new option designed to simplify self-administration of chronic interferon therapy.
The FDA has approved a prefilled pen for ropeginterferon alfa-2b-njft in adult patients with polycythemia vera, providing a new option designed to simplify self-administration of chronic interferon therapy.
Thank you for taking part in this brief survey. Your response will provide valuable insight into how clinicians manage polycythemia vera in clinical practice.
Thank you for taking part in this brief survey. Your response will provide valuable insight into how clinicians manage polycythemia vera in clinical practice.
Dr Michael Grunwald discusses practical patient counseling and symptom management strategies that can help support long-term disease control goals among patients with polycythemia vera.
Dr Michael Grunwald discusses practical patient counseling and symptom management strategies that can help support long-term disease control goals among patients with polycythemia vera.